Ariosa Asks USPTO To Nix Sequenom Prenatal Test Patent
Ariosa Diagnostics Inc. filed a petition for inter partes review Monday asking the U.S. Patent and Trademark Office to invalidate a prenatal blood test patent that Sequenom Inc. accuses Ariosa of...To view the full article, register now.
Already a subscriber? Click here to view full article